Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Urogenital Neoplasms 2Melanoma 2Colitis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Non Small Cell Lung Cancer Metastatic 1Mesothelioma 1Diarrhea 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

lorlatinib 3pembrolizumab 2osimertinib 2Radiotherapy 2atezolizumab 1Temozolomide 1Radiosurgery 1Paclitaxel 1Nivolumab 1Ipilimumab 1Fecal Microbiota Transplantation 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non Small Cell Lung Cancer Metastatic × Fecal Microbiota Transplantation × Thoracic × Clear all
NCT04951583 2024-08-07

FMT-LUMINATE

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Active not recruiting
45 enrolled
DermatologicThoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡